Terumo Interventional Systems, a division of Terumo Medical Corp., announced the nationwide availability of the Azur CX Peripheral Coil System (Azur CX), the first and only peripheral embolization coil designed to provide cross-sectional coverage incorporating the benefits of Terumo's hydrogel technology.

cardiac stem cell regeneration therapy translational medicine louisville study

A study in Stem Cells Translational Medicine shows that in rats, treating a heart attack with stem cells even weeks after the attack occurred can halt deterioration and help the heart regenerate itself. In addition, doctors delivered the cells using a patch that resulted in a higher survival rate for the stem cells and more of them migrating into the damaged tissue, where they created new blood vessels.

Micell Technologies Inc. announced that a peer reviewed article discussing imaging and clinical results of the Dessolve I trial of its MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES) was accepted for publication on the JACC Cardiovascular Interventions website. The paper, "First-in-Human Evaluation of a Bioabsorbable Polymer–Coated Sirolimus-Eluting Stent: Imaging and Clinical Results of the Dessolve I Trial (DES With Sirolimus and a Bioabsorbable Polymer for the Treatment of Patients With De Novo Lesion in the Native Coronary Arteries)", is planned to also appear in the October 2013 issue of JACC Cardiovascular Interventions.

Biotronik announced it has completed patient enrollment in the iliac arm of its Bioflex-I trial. Under the supervision of Mark Burket, M.D. and chief, Cardiovascular Division at the University of Toledo Medical Center, the trial will evaluate the safety and effectiveness of the Astron and Pulsar-18 stents in the treatment of peripheral vascular disease with a view towards gaining U.S. Food and Drug Administration (FDA) approval.

Imris announced U.S. Food and Drug Administration (FDA) clearance to market Visius iCT, the first and only ceiling-mounted intraoperative computed tomography (iCT) on the market.

The World Molecular Imaging Society (WMIS) held its sixth annual congress in Savannah, Ga. September 18-21.  The World Molecular Imaging Congress (WMIC) 2013 featured advancements in molecular multimodal imaging with a focus on discovery, pre-clinical and translational research, highlighting first-in-human studies that drive innovative diagnostics and targeted therapy critical to the implementation of precision medicine.  

At the University of Southern California Body Computing Conference, AliveCor Inc. announced its new versatile Heart Monitor, a device that easily attaches to any compatible smartphone or smartphone case.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now